Bank Of New York Mellon Corp Dynavax Technologies Corp Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$9.44 - $11.88 $10.7 Million - $13.5 Million	1,132,809 New	1,132,809 $11.1 Billion
Q4 2022 Feb 14, 2023	BUY	$10.27 - $13.29 $12 Million - $15.6 Million	1,173,193 New	1,173,193 $12.5 Million
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $356,884 - $626,793	35,940 Added 3.63%	1,027,276 $10.7 Million
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $4.74 Million - $8.17 Million	636,580 Added 179.44%	991,336 $12.5 Million
Q1 2022 May 11, 2022	SELL	$9.75 - $14.44 $142,749 - $211,416	-14,641 Reduced 3.96%	354,756 $3.85 Million
Q4 2021 Feb 11, 2022	SELL	$13.17 - $20.94 $444,540 - $706,808	-33,754 Reduced 8.37%	369,397 $5.2 Million
Q3 2021 Nov 12, 2021	BUY	$9.16 - $19.83 $777,216 - $1.68 Million	84,849 Added 26.66%	403,151 $7.75 Million
Q2 2021 Aug 11, 2021	SELL	$7.25 - $10.99 $635,150 - $962,800	-87,607 Reduced 21.58%	318,302 $3.14 Million
Q1 2021 May 13, 2021	SELL	$4.57 - $11.18 $72,402 - $177,124	-15,843 Reduced 3.76%	405,909 $3.99 Million
Q4 2020 Feb 09, 2021	BUY	$3.73 - $5.6 $11,167 - $16,766	2,994 Added 0.71%	421,752 $1.88 Million
Q3 2020 Nov 12, 2020	BUY	$4.32 - $11.7 $165,533 - $448,320	38,318 Added 10.07%	418,758 $1.81 Million
Q2 2020 Aug 12, 2020	BUY	$2.94 - $9.1 $97,284 - $301,119	33,090 Added 9.53%	380,440 $3.37 Million
Q1 2020 May 06, 2020	SELL	$2.27 - $6.2 $46,153 - $126,058	-20,332 Reduced 5.53%	347,350 $1.23 Million
Q4 2019 Feb 14, 2020	BUY	$3.46 - $6.93 $259,392 - $519,535	74,969 Added 25.61%	367,682 $2.1 Million
Q3 2019 Nov 07, 2019	BUY	$2.69 - $4.85 $75,379 - $135,906	28,022 Added 10.59%	292,713 $1.05 Million
Q2 2019 Aug 12, 2019	SELL	$3.65 - $7.89 $42,088 - $90,979	-11,531 Reduced 4.17%	264,691 $1.06 Million
Q1 2019 May 14, 2019	BUY	$7.08 - $12.09 $2,902 - $4,956	410 Added 0.15%	276,222 $2.02 Million
Q4 2018 Feb 11, 2019	BUY	$8.14 - $13.28 $3,386 - $5,524	416 Added 0.15%	275,812 $2.52 Million
Q3 2018 Nov 09, 2018	SELL	$11.85 - $16.0 $1,173 - $1,584	-99 Reduced 0.04%	275,396 $0
Q2 2018 Aug 06, 2018	SELL	$15.15 - $20.75 $438,168 - $600,131	-28,922 Reduced 9.5%	275,495 $4.2 Million
Q1 2018 May 15, 2018	BUY	$14.65 - $19.9 $29,988 - $40,735	2,047 Added 0.68%	304,417 $6.04 Million
Q4 2017 Feb 09, 2018	BUY	$17.3 - $24.08 $5.23 Million - $7.28 Million	302,370	302,370 $5.65 Million

Others Institutions Holding DVAX

# of Institutions

273

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

Black Rock Inc. New York, NY

21.9M
Shares

$277 Million
0.01% of portfolio
Deep Track Capital, LP Greenwich, CT

12.5M
Shares

$158 Million
5.15% of portfolio
Vanguard Group Inc Valley Forge, PA

9.22M
Shares

$116 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

8.33M
Shares

$105 Million
7.62% of portfolio
State Street Corp Boston, MA

7.69M
Shares

$97.1 Million
0.0% of portfolio

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.6B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account